essential therapeutic approach for treating some genetic disorders,
injuries, and cancers. However, immune-mediated transplant
rejection can limit the effectiveness of this approach. Rejection
of transplanted tissues, which can occur via one of three
hypersensitivity reactions (type II, III, or IV), can occur almost
immediately after transplantation as a hyperacute rejection, or
later on as an acute or chronic rejection. The location of antigens
(i.e., cell-associated or soluble) and the type of immune response
initiated (i.e., antibody or T cell–mediated) determine which
hypersensitivity reaction is responsible for the rejection. In
addition to immune responses of the recipient attacking
transplanted donor tissues, the donor's immune cells in
transplanted tissues can attack cells of the recipient. To optimize
the selection of compatible donor tissues, the most appropriate
clinical screening test is performed based on the type of
hypersensitivity reaction that would lead to transplant rejection.
Immunosuppressive drugs are also effective in limiting the
rejection of most solid organ transplants, but they are not as
effective in limiting the rejection of liquid transplants.
Please draw lines between related items and write one
word above the line to indicate how these items are related. For
example, if the terms were "B cell" and "IgM antibody," you could
connect these terms by writing "produces" above a line with an
arrow going from B cell to IgM. In the end, all 12 items in this
list should be connected and related to each other.
draw a line and connect from left column to right column
and explain their connection.
- Liquid And Solid Tissue Or Organ Transplantation Is An Essential Therapeutic Approach For Treating Some Genetic Disord 1 (29.69 KiB) Viewed 172 times